Triptans Not Working? Why — and What a Neurologist Tries Next

Written and medically reviewed by Tae Ho Guak, MD, board-certified neurologist · Reviewed July 2026 · Editorial policy

When a patient tells me “triptans don’t work for me,” I have learned not to believe it right away — not because I doubt them, but because in my clinic that sentence turns out to mean four very different things, and only one of them is true triptan failure. Most of the time the drug is right and something around it is wrong: it is taken too late, the dose is too low, it is being absorbed into a stomach that has stopped moving, the wrong triptan was chosen, or the headache being treated was never a migraine attack in the first place. Before I abandon a class of drugs that has helped migraine patients for thirty years, I work through those possibilities in order. Here is how I do it, and what I reach for when the triptan really has failed.

First: are you taking it too late?

This is, by a wide margin, the most common reason a triptan “doesn’t work.” Triptans act on the trigeminovascular system early in an attack. Once central sensitization has set in — the point where brushing your hair hurts, where your scalp or the skin around your eye feels raw and tender (this is called cutaneous allodynia) — the same dose that would have aborted the attack an hour earlier now barely dents it. Patients arrive at that point honestly and reasonably: they wait to see whether it is “a real one,” they try to get through a meeting, they hope it will fade.

So my first question is never “which triptan?” It is “how many minutes after the pain starts do you swallow it?” If the answer is more than an hour, or if the answer is “once I’m sure,” we have found the problem. I ask patients to treat within the first 20–30 minutes, while the pain is still mild — and to accept that occasionally they will treat an attack that would have stayed mild anyway. That is a fair trade. A headache diary is the fastest way to see this pattern; if you have never kept one, my guide on how to keep a headache diary that actually works covers what to record.

Second: is the drug even getting absorbed?

Migraine slows the stomach. Gastric stasis is part of the attack itself, not just a consequence of the nausea, and it means an oral tablet can sit undissolved while the attack builds. If your attacks come with significant nausea or vomiting, or if you routinely wake up with the headache already fully formed, an oral tablet may be the wrong delivery route entirely — not the wrong molecule.

The options here are practical. Subcutaneous sumatriptan (4 mg or 6 mg) bypasses the gut completely and works fastest of anything in the class — it is what I use for patients who vomit early, and it is standard for cluster headache. Nasal sprays (sumatriptan, zolmitriptan) are an intermediate step. Adding an antiemetic such as metoclopramide can improve absorption of an oral dose and treat the nausea at once. I have had patients labeled “triptan non-responders” for years who responded to the very same drug the first time they took it by injection. The pattern of nausea-with-headache is worth understanding on its own; I wrote about why the gut is involved in headache with indigestion.

Third: have you actually tried more than one triptan?

There are seven triptans, and they are not interchangeable in practice. They differ in how fast they reach peak concentration, how long they last, and how well they are tolerated. Failing one does not predict failing another, and the data support switching: a meaningful proportion of patients who get nothing from sumatriptan respond to eletriptan or rizatriptan.

How I choose depends on the failure mode. If the drug works but the headache comes back within 24 hours — recurrence, which is common with sumatriptan — I move to a longer-acting agent such as frovatriptan or naratriptan, which is also the basis of mini-prophylaxis around menstruation (I cover that in hormonal migraine prevention). If the drug simply does nothing, I try a faster, more potent one — eletriptan 40–80 mg or rizatriptan 10 mg. If side effects are the problem — the chest tightness, the heaviness, the flushing — naratriptan or frovatriptan are gentler. Before declaring true triptan failure, I want to see at least two different triptans tried, each at an adequate dose, each taken early, each across two or three attacks. One bad experience with one tablet is not a verdict.

Fourth: are painkillers themselves keeping the headache alive?

This is the possibility patients least want to hear, and the one I find most often in people whose triptans “used to work and then stopped.” Triptans taken on 10 or more days a month — or simple analgesics on 15 or more days — can drive medication-overuse headache, a state in which the background headache becomes near-daily and every acute drug, including the triptan, loses its edge. The medication is no longer treating the headache; it has become part of it.

The tell-tale history is a slow creep: two triptans a month becomes one a week becomes three a week, the attacks blur into each other, and the patient concludes the drug has “stopped working” when the real problem is how often it is being taken. The way out is not another acute drug — it is withdrawal of the overused one, usually with a preventive started at the same time, and it is genuinely uncomfortable for one to two weeks before it gets better. It is also, in my experience, the single change that most often turns a stuck patient around. If you are taking something for headache more than twice a week, read medication-overuse headache before you change anything else.

When it really is triptan failure: what comes next

If two triptans, taken early and at full dose, have honestly failed — or if you cannot take them at all because of coronary artery disease, uncontrolled hypertension, prior stroke, or hemiplegic migraine — the good news is that this is no longer the end of the road it was a decade ago.

Gepants (rimegepant, ubrogepant, and atogepant for prevention) block the CGRP receptor. They do not constrict blood vessels, which makes them usable in patients with cardiovascular contraindications to triptans, and they do not appear to cause medication-overuse headache in the way triptans do. They are typically slower to act than a triptan but are effective in patients who have failed one — the trials specifically included triptan non-responders. I explain the class in gepants for migraine.

Lasmiditan, a 5-HT1F agonist, relieves attacks without vasoconstriction. Its limitation is real: it causes dizziness and sedation, and you cannot drive for eight hours after a dose.

Prevention. Here is the point I most want to make. When a patient needs an acute drug more than about twice a week, the acute drug is not the problem to solve — the attack frequency is. Reaching for a better rescue medication while attacks come ten times a month is treating the smoke. CGRP monoclonal antibodies (erenumab, galcanezumab, fremanezumab, eptinezumab), topiramate, beta-blockers, amitriptyline, and candesartan all reduce how often attacks arrive, and a good preventive often makes a previously “useless” triptan start working again, simply because there are fewer, milder attacks to abort. I go through the injectables in CGRP injections for migraine.

One more possibility: it was never migraine

Triptans work on migraine and on the trigeminal autonomic cephalalgias. They do very little for tension-type headache, nothing for cervicogenic pain, and nothing for the secondary headaches that need a different diagnosis altogether. A triptan that fails consistently, in a patient taking it correctly and early, is a reason to revisit the diagnosis — not simply to escalate the prescription. In my clinic, a persistent “non-responder” fairly often turns out to have medication-overuse headache, a hemicrania continua that responds dramatically to indomethacin, or a headache that was never correctly named. That is the argument I make at length in why your headache isn’t getting better.

A drug that does not work is information. It should send you back to the diagnosis, not just to the pharmacy.

---

Next steps

• Free headache red-flag checklist — the warning signs that mean your headache needs to be evaluated now, not later.
• Talk to a headache specialist — if two triptans have failed and no one has re-examined your diagnosis, that conversation is overdue.

Dr. Tae Ho Guak, MD, is a board-certified neurologist with 25 years of practice and over 100,000 patient consultations.

This article is for educational purposes only and does not replace a consultation with your own physician. Medication choices depend on your individual history and contraindications. If you have a sudden, severe, “worst-ever” headache, a headache with fever and neck stiffness, weakness, confusion, or vision loss, go to an emergency department immediately.

References

• American Headache Society. Consensus statement: integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021–1039.
• Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.
• Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001;358(9294):1668–1675.

This article was written and medically reviewed by Tae Ho Guak, MD, a board-certified neurologist. Last reviewed July 2026. See our editorial policy.